Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
28 Total results for product and free and sample content found
Biomedtracker
05 Apr 2018
What’s on the horizon for pharma in 2018? Find out with Biomedtracker’s Early 2018 Outlook Report extract. Download free extracts from this essential report, which investigates the catalysts expected to occur in the first part of the year for 21 different drugs.
Biomedtracker
27 Oct 2017
In this report, we cover catalysts from 21 drugs expected to occur in Q4 2017. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.
Topic Alzheimers Cancer Drug approval
Pharmaprojects
10 Oct 2017
The UK has some of the world’s most exciting science, a supportive business environment, and strong companies led by experienced management teams.
Topic BioPharmaceutical
Medtrack
25 Sep 2017
The 23rd Annual International Partnering Conference, Bio Europe 2017, November 6 – 8, in Berlin, Germany is fast approaching. Via one-on-one partnering meetings, attendees over the world from all facets of biotech will meet at Europe’s largest life science partnering conference to identify, engage with, and enter into strategic relationships to drive their business forward.
Topic Clinical trials
Datamonitor Healthcare
By Ljlal Syed, Mark Lansdell and David Abramson 19 Sep 2017
This report examines the extent to which order of market entry influences the prospects of achieving a satisfactory return on investment for companies developing branded generic
Topic Deal trends
Datamonitor Healthcare
By Colin White, Robert Jeng & Jolene Lau 19 Sep 2017
This is an overview of the field of immuno-oncology and the various immuno-oncology classes. Immuno-oncology is one of the most promising and fastest growing areas of cancer research, as well
Topic immuno-oncology
Medtrack
By Steven Muntner 16 Sep 2017
Royalty payments are an essential component of most pharmaceutical deals. Along with upfront payments and milestones, companies are rewarded for surpassing certain developmental hurdles.
Topic Deal trends Medtech
Datamonitor Healthcare
05 Aug 2017
Big Pharma Outlook 2026 takes decade-long look at what’s in store for the future of Big Pharma.
Biomedtracker
17 Jul 2017
In this report, we cover catalysts from 21 drugs expected to occur in Q3 2017. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.
Topic Alzheimers Cancer Drug approval
No Records Found
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Report store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
